Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Digestive Neuroendocrine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05316480
What this trial is testing

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Who this might be right for
Pancreatic Neuroendocrine Neoplasm
Fudan University 42
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Testing effectiveness (Phase 2)UnknownNCT00610389
What this trial is testing

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaCarcinoma, Hepatocellular
Clinica Universidad de Navarra, Universidad de Navarra 27
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Not applicableLooking for participantsNCT04792463
What this trial is testing

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Who this might be right for
Uveal MelanomaCutaneous MelanomaBAP1 Gene Mutation+5 more
Mohamed Abdel-Rahman 500
Testing effectiveness (Phase 2)Study completedNCT00378482
What this trial is testing

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Who this might be right for
Colorectal NeoplasmsMelanomaProstatic Neoplasms+3 more
AstraZeneca 37
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Not applicableAvailableNCT07262970
What this trial is testing

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Who this might be right for
Tumor-associated Hyperinsulinism (Tumor HI)
Rezolute
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247905
What this trial is testing

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorUnresectable Pancreatic Neuroendocrine Carcinoma
Alliance for Clinical Trials in Oncology 31
Not applicableStudy completedNCT02129049
What this trial is testing

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Who this might be right for
Breast CancerCervical CancerColon Cancer+5 more
University of Washington 35
Not applicableStudy completedNCT04604158
What this trial is testing

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Who this might be right for
CancerCancer MetastaticNeoplasms+20 more
Gillian Gresham 38
Testing effectiveness (Phase 2)Looking for participantsNCT06506643
What this trial is testing

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

Who this might be right for
CLLSolid Tumor, Adult
Vector Vitale LLC 36
Testing effectiveness (Phase 2)Study completedNCT01229943
What this trial is testing

Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Pancreatic Neuroendocrine TumorLocally Advanced Pancreatic Neuroendocrine TumorPancreatic Gastrinoma+3 more
National Cancer Institute (NCI) 150
Not applicableStudy completedNCT01528774
What this trial is testing

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

Who this might be right for
Melanoma
Wolfram Samlowski 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05988918
What this trial is testing

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Who this might be right for
Pancreatic AdenocarcinomaAdenosquamous CarcinomaPancreatic Neuroendocrine Tumor+4 more
University of Michigan Rogel Cancer Center 17
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07121478
What this trial is testing

Patients With High-grade Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor of PancreasPancreatic Neuroendocrine Tumors
National Cancer Center, Korea 46
Early research (Phase 1)Study completedNCT00667082
What this trial is testing

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

Who this might be right for
Non-Small Cell Lung CancerPancreatic CancerMelanoma+2 more
Celgene 22
Next Page